BLUEPRINT MEDICINES CORPORATION Increase (Decrease) in Accounts Receivable
BLUEPRINT MEDICINES CORPORATION reported Increase (Decrease) in Accounts Receivable of $1.40 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-01.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2025-05-01
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in accounts receivable for the quarter ending 2025-03-31 was $1.40M, a 91.94% decline year-over-year.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in accounts receivable for the quarter ending 2024-12-31 was $10.33M, a 491.92% increase year-over-year.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in accounts receivable for the quarter ending 2024-09-30 was -$19.89M, a 439.15% decline year-over-year.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in accounts receivable for the quarter ending 2024-06-30 was $25.07M, a 207.36% increase year-over-year.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in accounts receivable for fiscal 2024 was $32.84M, a 58.56% increase from fiscal 2023.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in accounts receivable for fiscal 2023 was $20.71M.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in accounts receivable for fiscal 2022 was -$1.57M, a 108.66% decline from fiscal 2021.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in accounts receivable for fiscal 2021 was $18.14M, a 184.06% increase from fiscal 2020.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2025-03-31 | $1.40M 10-Q · filed 2025-05-01 | $11.73M derived: sum of 2 quarters · filed 2025-05-01 | -$8.16M derived: sum of 3 quarters · filed 2025-05-01 | $16.90M derived: sum of 4 quarters · filed 2025-05-01 |
| 2024-12-31 | $10.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | -$9.56M derived: sum of 2 quarters · filed 2025-02-13 | $15.51M derived: sum of 3 quarters · filed 2025-02-13 | $32.84M 10-K · filed 2025-02-13 |
| 2024-09-30 | -$19.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $5.18M derived: sum of 2 quarters · filed 2024-10-30 | $22.52M 10-Q · filed 2024-10-30 | $24.26M derived: sum of 4 quarters · filed 2025-05-01 |
| 2024-06-30 | $25.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $42.41M 10-Q · filed 2024-08-01 | $44.15M derived: sum of 3 quarters · filed 2025-05-01 | $50.02M derived: sum of 4 quarters · filed 2025-05-01 |
| 2024-03-31 | $17.34M 10-Q · filed 2025-05-01 | $19.08M derived: sum of 2 quarters · filed 2025-05-01 | $24.95M derived: sum of 3 quarters · filed 2025-05-01 | $33.10M derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $7.61M derived: sum of 2 quarters · filed 2025-02-13 | $15.77M derived: sum of 3 quarters · filed 2025-02-13 | $20.71M 10-K · filed 2025-02-13 |
| 2023-09-30 | $5.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $14.02M derived: sum of 2 quarters · filed 2024-10-30 | $18.97M 10-Q · filed 2024-10-30 | $22.95M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $8.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $13.11M 10-Q · filed 2024-08-01 | $17.09M derived: sum of 3 quarters · filed 2025-02-13 | $9.40M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $4.95M 10-Q · filed 2024-05-02 | $8.93M derived: sum of 2 quarters · filed 2025-02-13 | $1.25M derived: sum of 3 quarters · filed 2025-02-13 | -$268.00K derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $3.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | -$3.70M derived: sum of 2 quarters · filed 2025-02-13 | -$5.22M derived: sum of 3 quarters · filed 2025-02-13 | -$1.57M 10-K · filed 2025-02-13 |
| 2022-09-30 | -$7.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | -$9.20M derived: sum of 2 quarters · filed 2023-10-26 | -$5.55M 10-Q · filed 2023-10-26 | $1.22M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | -$1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $2.13M 10-Q · filed 2023-08-02 | $8.90M derived: sum of 3 quarters · filed 2024-02-15 | $1.86M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $3.65M 10-Q · filed 2023-05-04 | $10.41M derived: sum of 2 quarters · filed 2024-02-15 | $3.38M derived: sum of 3 quarters · filed 2024-02-15 | -$5.83M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $6.77M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | -$264.00K derived: sum of 2 quarters · filed 2024-02-15 | -$9.47M derived: sum of 3 quarters · filed 2024-02-15 | $18.14M 10-K · filed 2024-02-15 |
| 2021-09-30 | -$7.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | -$16.24M derived: sum of 2 quarters · filed 2022-11-01 | $11.38M 10-Q · filed 2022-11-01 | -$25.94M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | -$9.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $18.41M 10-Q · filed 2022-08-02 | -$18.91M derived: sum of 3 quarters · filed 2023-02-16 | $22.05M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $27.61M 10-Q · filed 2022-05-03 | -$9.71M derived: sum of 2 quarters · filed 2023-02-16 | $31.26M derived: sum of 3 quarters · filed 2023-02-16 | $30.15M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | -$37.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $3.65M derived: sum of 2 quarters · filed 2023-02-16 | $2.54M derived: sum of 3 quarters · filed 2023-02-16 | $6.39M 10-K · filed 2023-02-16 |
| 2020-09-30 | $40.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $39.86M derived: sum of 2 quarters · filed 2021-10-28 | $43.70M 10-Q · filed 2021-10-28 | $41.95M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-06-30 | -$1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $2.74M 10-Q · filed 2021-07-29 | $989.00K derived: sum of 3 quarters · filed 2022-02-17 | $2.65M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-03-31 | $3.85M 10-Q · filed 2021-04-29 | $2.10M derived: sum of 2 quarters · filed 2022-02-17 | $3.76M derived: sum of 3 quarters · filed 2022-02-17 | $4.12M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-12-31 | -$1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | -$87.00K derived: sum of 2 quarters · filed 2022-02-17 | $276.00K derived: sum of 3 quarters · filed 2022-02-17 | $599.00K 10-K · filed 2022-02-17 |
| 2019-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $2.03M derived: sum of 2 quarters · filed 2020-10-29 | $2.35M 10-Q · filed 2020-10-29 | $2.41M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-06-30 | $363.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $686.00K 10-Q · filed 2020-07-30 | $750.00K derived: sum of 3 quarters · filed 2021-02-17 | $750.00K derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-03-31 | $323.00K 10-Q · filed 2020-05-06 | $387.00K derived: sum of 2 quarters · filed 2021-02-17 | $387.00K derived: sum of 3 quarters · filed 2021-02-17 | |
| 2018-12-31 | $64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $64.00K derived: sum of 2 quarters · filed 2021-02-17 | -$349.00K 10-K · filed 2021-02-17 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$413.00K 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | -$413.00K 10-Q · filed 2019-08-01 | |||
| 2017-12-31 | $413.00K 10-K · filed 2020-02-13 |